Suven Pharmaceuticals Ltd consolidated Q1FY24 PAT at Rs. 120.58 crores

Suven Pharmaceuticals Limited has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 358.2152 crores during the period ended June 30, 2023 as compared to Rs. 380.7557 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 120.5899 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 123.9713 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 4.74 for the period ended June 30, 2023 as compared to Rs. 4.87 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 358.2152 crs	₹380.7557 crs	-5.92%
Net Profit	₹120.5899 crs	₹123.9713 crs	-2.73%
EPS	₹4.74	₹4.87	-2.67%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 358.2152 crores during the period ended June 30, 2023 as compared to Rs.349.8322 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.120.5899 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.107.5421 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.4.74 for the period ended June 30, 2023 as compared to Rs.4.22 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 358.2152 crs	₹349.8322 crs	2.40%
Net Profit	₹120.5899 crs	₹107.5421 crs	12.13%
EPS	₹4.74	₹4.22	12.32%

Shares of Suven Pharmaceuticals Limited was last trading in BSE at Rs. 489.00 as compared to the previous close of Rs. 490.60. The total number of shares traded during the day was 15008 in over 856 trades.

The stock hit an intraday high of Rs. 492.70 and intraday low of 477.10. The net turnover during the day was Rs. 7336684.00.

Source : Equity Bulls

Keywords

SuvenPharmaceuticals Q1FY24 ResultUpdate